Literature DB >> 19297325

LFA-1 affinity regulation is necessary for the activation and proliferation of naive T cells.

Yang Wang1, Dan Li, Roza Nurieva, Justin Yang, Mehmet Sen, Roberto Carreño, Sijie Lu, Bradley W McIntyre, Jeffrey J Molldrem, Glen B Legge, Qing Ma.   

Abstract

The activation of LFA-1 (lymphocyte function-associated antigen) is a critical event for T cell co-stimulation. The mechanism of LFA-1 activation involves both affinity and avidity regulation, but the role of each in T cell activation remains unclear. We have identified antibodies that recognize and block different affinity states of the mouse LFA-1 I-domain. Monoclonal antibody 2D7 preferentially binds to the low affinity conformation, and this specific binding is abolished when LFA-1 is locked in the high affinity conformation. In contrast, M17/4 can bind both the locked high and low affinity forms of LFA-1. Although both 2D7 and M17/4 are blocking antibodies, 2D7 is significantly less potent than M17/4 in blocking LFA-1-mediated adhesion; thus, blocking high affinity LFA-1 is critical for preventing LFA-1-mediated adhesion. Using these reagents, we investigated whether LFA-1 affinity regulation affects T cell activation. We found that blocking high affinity LFA-1 prevents interleukin-2 production and T cell proliferation, demonstrated by TCR cross-linking and antigen-specific stimulation. Furthermore, there is a differential requirement of high affinity LFA-1 in the activation of CD4(+) and CD8(+) T cells. Although CD4(+) T cell activation depends on both high and low affinity LFA-1, only high affinity LFA-1 provides co-stimulation for CD8(+) T cell activation. Together, our data demonstrated that the I-domain of LFA-1 changes to the high affinity state in primary T cells, and high affinity LFA-1 is critical for facilitating T cell activation. This implicates LFA-1 activation as a novel regulatory mechanism for the modulation of T cell activation and proliferation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19297325      PMCID: PMC2675993          DOI: 10.1074/jbc.M807207200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  Structural biology. Changing partners.

Authors:  Richard O Hynes
Journal:  Science       Date:  2003-05-02       Impact factor: 47.728

2.  Structures of the alpha L I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation.

Authors:  Motomu Shimaoka; Tsan Xiao; Jin-Huan Liu; Yuting Yang; Yicheng Dong; Chang-Duk Jun; Alison McCormack; Rongguang Zhang; Andrzej Joachimiak; Junichi Takagi; Jia-Huai Wang; Timothy A Springer
Journal:  Cell       Date:  2003-01-10       Impact factor: 41.582

Review 3.  Structural basis of integrin regulation and signaling.

Authors:  Bing-Hao Luo; Christopher V Carman; Timothy A Springer
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

Review 4.  Cell adhesion molecules and actin cytoskeleton at immune synapses and kinapses.

Authors:  Michael L Dustin
Journal:  Curr Opin Cell Biol       Date:  2007-10-17       Impact factor: 8.382

Review 5.  Efalizumab: a review of events reported during clinical trials and side effects.

Authors:  Noah Scheinfeld
Journal:  Expert Opin Drug Saf       Date:  2006-03       Impact factor: 4.250

6.  Shear flow-dependent integration of apical and subendothelial chemokines in T-cell transmigration: implications for locomotion and the multistep paradigm.

Authors:  Taylor H Schreiber; Vera Shinder; Derek W Cain; Ronen Alon; Robert Sackstein
Journal:  Blood       Date:  2006-10-12       Impact factor: 22.113

7.  Importance of force linkage in mechanochemistry of adhesion receptors.

Authors:  Nathan S Astrof; Azucena Salas; Motomu Shimaoka; JianFeng Chen; Timothy A Springer
Journal:  Biochemistry       Date:  2006-12-19       Impact factor: 3.162

8.  RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1.

Authors:  Koko Katagiri; Akito Maeda; Mika Shimonaka; Tatsuo Kinashi
Journal:  Nat Immunol       Date:  2003-07-06       Impact factor: 25.606

9.  The connection between metal ion affinity and ligand affinity in integrin I domains.

Authors:  Thomas Vorup-Jensen; Travis T Waldron; Nathan Astrof; Motomu Shimaoka; Timothy A Springer
Journal:  Biochim Biophys Acta       Date:  2007-07-12

Review 10.  Clinical trials of transplant tolerance: slow but steady progress.

Authors:  Jeffrey B Matthews; Eleanor Ramos; Jeffrey A Bluestone
Journal:  Am J Transplant       Date:  2003-07       Impact factor: 8.086

View more
  30 in total

1.  Immature T-cell clustering and efficient differentiation require the polarity protein Scribble.

Authors:  Kelly A Pike; Sarang Kulkarni; Tony Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-28       Impact factor: 11.205

2.  2E8 binds to the high affinity I-domain in a metal ion-dependent manner: a second generation monoclonal antibody selectively targeting activated LFA-1.

Authors:  Roberto Carreño; Wells S Brown; Dan Li; Jessica A Hernandez; Yang Wang; Tae Kon Kim; John W Craft; Krishna V Komanduri; Laszlo G Radvanyi; Patrick Hwu; Jeffrey J Molldrem; Glen B Legge; Bradley W McIntyre; Qing Ma
Journal:  J Biol Chem       Date:  2010-08-19       Impact factor: 5.157

3.  Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain.

Authors:  Dongfen Yuan; Yuling Zhao; William A Banks; Kristin M Bullock; Matthew Haney; Elena Batrakova; Alexander V Kabanov
Journal:  Biomaterials       Date:  2017-07-10       Impact factor: 12.479

4.  Gene related to anergy in lymphocytes (GRAIL) expression in CD4+ T cells impairs actin cytoskeletal organization during T cell/antigen-presenting cell interactions.

Authors:  Jill M Schartner; William T Simonson; Sarah A Wernimont; Lauren M Nettenstrom; Anna Huttenlocher; Christine M Seroogy
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

5.  Selective Targeting of High-Affinity LFA-1 Does Not Augment Costimulation Blockade in a Nonhuman Primate Renal Transplantation Model.

Authors:  K P Samy; D J Anderson; D J Lo; M S Mulvihill; M Song; A B Farris; B S Parker; A L MacDonald; C Lu; T A Springer; S C Kachlany; K A Reimann; T How; F V Leopardi; K S Franke; K D Williams; B H Collins; A D Kirk
Journal:  Am J Transplant       Date:  2017-01-27       Impact factor: 8.086

6.  IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis.

Authors:  Jacqueline Unsinger; Margaret McGlynn; Kevin R Kasten; Andrew S Hoekzema; Eizo Watanabe; Jared T Muenzer; Jacquelyn S McDonough; Johannes Tschoep; Thomas A Ferguson; Jonathan E McDunn; Michel Morre; David A Hildeman; Charles C Caldwell; Richard S Hotchkiss
Journal:  J Immunol       Date:  2010-03-03       Impact factor: 5.422

7.  DOCK8 is essential for LFA-1-dependent positioning of T follicular helper cells in germinal centers.

Authors:  Erin Janssen; Mira Tohme; Jordan Butts; Sophie Giguere; Peter T Sage; Francisco E Velázquez; Christy Kam; Elena Milin; Mrinmoy Das; Ali Sobh; Salem Al-Tamemi; Francis W Luscinskas; Facundo Batista; Raif S Geha
Journal:  JCI Insight       Date:  2020-08-06

8.  Sedative drug modulates T-cell and lymphocyte function-associated antigen-1 function.

Authors:  Koichi Yuki; Sulpicio G Soriano; Motomu Shimaoka
Journal:  Anesth Analg       Date:  2011-03-08       Impact factor: 5.108

9.  Systemic Delivery of Anti-Integrin αL Antibodies Reduces Early Macrophage Recruitment, Inflammation, and Scar Formation in Murine Burn Wounds.

Authors:  Xanthe L Strudwick; Damian H Adams; Natasha T Pyne; Michael S Samuel; Rachael Z Murray; Allison J Cowin
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-01-28       Impact factor: 4.730

10.  Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.

Authors:  Yang Wang; Dan Li; Dan Jones; Roland Bassett; George E Sale; Jahan Khalili; Krishna V Komanduri; Daniel R Couriel; Richard E Champlin; Jeffrey J Molldrem; Qing Ma
Journal:  Biol Blood Marrow Transplant       Date:  2009-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.